Bone Marrow TransplantationBlood DonorsBone MarrowTransplantation, HomologousBone Marrow CellsGraft vs Host DiseaseTransplantation, AutologousTissue DonorsWhole-Body IrradiationBone and BonesAnemia, AplasticTransplantation ConditioningHematopoietic Stem Cell TransplantationLiver TransplantationLeukemiaTransplantation ChimeraGraft SurvivalBusulfanBone Marrow PurgingHistocompatibility TestingHistocompatibilityHematopoietic Stem CellsTransplantation, IsogeneicKidney TransplantationCyclophosphamideBone Marrow DiseasesHematopoiesisRecurrenceCombined Modality TherapyRadiation ChimeraMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLeukemia, Myeloid, AcuteBone Marrow ExaminationGraft RejectionTime FactorsTreatment OutcomeImmunosuppressive AgentsHematologic NeoplasmsRemission InductionPrecursor Cell Lymphoblastic Leukemia-LymphomaHepatic Veno-Occlusive DiseaseBone RemodelingTransplantation ImmunologyBone Marrow NeoplasmsGraft vs Host ReactionLiving DonorsLeukemia, MyeloidImmunosuppressionLeukocyte TransfusionLymphocyte DepletionHeart TransplantationStem Cell TransplantationAcute DiseaseLymphoma, Non-HodgkinHLA AntigensRetrospective StudiesT-LymphocytesSevere Combined ImmunodeficiencyChimeraColony-Forming Units AssaySurvival AnalysisMyelodysplastic SyndromesLung TransplantationCyclosporineActuarial AnalysisBlood TransfusionHematologic DiseasesBone DensityLymphocyte TransfusionCytomegalovirus InfectionsOrgan TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsFollow-Up StudiesCarmustineGraft vs Tumor EffectCell DifferentiationPancytopeniaLeukocyte CountSurvival RateGraft vs Leukemia EffectCytarabineSpleenGranulocyte Colony-Stimulating FactorFlow CytometryMice, Inbred BALB CBone ResorptionMelphalanDisease-Free SurvivalCells, CulturedEtoposidePolymerase Chain ReactionLymphomaMultiple MyelomaFatal OutcomeInfectionAntigens, CD34PrognosisMice, Knockout